Court, Explained
U.S. Federal District Courts
←Back to docket
S.D.N.Y.Procedural orderFiled July 24, 2023

Iglesias v. HRA Pharma America, Inc.

Judge
Rearden
Docket
1:22-cv-08398
Court
U.S. District Court · Southern District of New York
Pages
8
DiscoveryCivil Procedure
In one sentence

In Iglesias v. HRA Pharma, Judge Rearden issued a protective order governing confidential discovery and limiting its use.

Who this affects

The order binds the parties and their representatives, agents, experts, consultants, certain witnesses and service providers, third parties providing discovery, court personnel, and other people with actual or constructive notice who receive or access designated confidential discovery material.

What happened

In Iglesias v. HRA Pharma America, Inc., the parties asked the court to protect certain non-public information exchanged during discovery. The plaintiff is Isaac Iglesias, individually and on behalf of others similarly situated, and the defendant is HRA Pharma America, Inc.

The order allows parties to label qualifying financial, business, product, personal, and other information as confidential. People who receive that information generally may disclose it only to specified participants, such as the parties, counsel, experts, certain witnesses, service providers, mediators, and the court, with confidentiality agreements required in several situations. The information may be used only for this case and related appeals, not for business purposes or other proceedings.

Judge Jennifer H. Rearden found good cause and ordered the protective order on July 24, 2023. The order also establishes procedures for challenging confidentiality designations, filing confidential material with the court, handling accidentally disclosed privileged material, responding to subpoenas, and returning or destroying confidential discovery after the case ends. It warns that willful violations could result in contempt of court.

The detailed version

For law students, journalists, and other readers who want the full reasoning

Case
Iglesias v. HRA Pharma America, Inc. · No. 1:22-cv-08398
Judge
Rearden
Date
July 24, 2023

Background

Isaac Iglesias, individually and on behalf of all others similarly situated, sued HRA Pharma America, Inc. The parties, through counsel, agreed to a protective order under Federal Rule of Civil Procedure 26(c) because discovery was expected to include confidential documents or information. The court found good cause to issue a tailored order for the pretrial phase of the case.

Confidential information

The order permits a producing person to designate as confidential only information whose disclosure is restricted by law or would harm the producing person’s or a third party’s business, commercial, financial, or personal interests. Listed categories include previously undisclosed financial information; information about ownership or control of a non-public company; business plans; product formulation and manufacturing information; research, studies, testing, product-development information, claim-substantiation materials, and marketing plans; personal or intimate information; and other categories later given confidential status by the court.

The producing person or counsel must mark protected portions of discovery material. Deposition testimony may be designated during the deposition or within 30 days afterward, and the entire transcript is treated as confidential during that 30-day period. A producing person may also correct an earlier failure to designate material as confidential by notifying prior recipients before trial.

Disclosure and use restrictions

Recipients may disclose confidential discovery material only to the groups identified in the order. These include the parties and their insurers and counsel; counsel retained for the case and their staff; litigation-support vendors; mediators or arbitrators; certain persons identified on a document; potential witnesses; experts and other specialized advisers; deposition stenographers; and the court and related appellate personnel. Before disclosure to several of these groups, the recipient must receive the order and sign a non-disclosure agreement.

The material may be used only to prosecute or defend this action and any appeals. It may not be used for business, commercial, competitive, or other litigation purposes. The order does not restrict a person’s use of that person’s own documents or information, or information obtained independently of the discovery process. It also does not waive objections to discovery, privileges, or arguments about whether evidence may be admitted at trial.

Challenges, court filings, and compelled disclosure

A party may object to a confidentiality designation or request additional disclosure limits, including an attorneys’-eyes-only designation in extraordinary circumstances. If the parties cannot resolve the issue, they must present the dispute to the court under the court’s individual rules.

The order does not automatically allow confidential material to be filed under seal. A party seeking to file documents under seal must submit a letter-motion explaining the basis for sealing and must publicly file a redacted version while filing the unredacted version under seal. The court retains discretion over whether confidential treatment is appropriate and states that it is unlikely to seal material introduced into evidence at trial.

If a party receives a discovery request for information subject to a third party’s confidentiality obligation, the party must notify the third party within five business days. If neither the third party nor the receiving party seeks court relief within 21 days after that notice, the receiving party must produce the responsive information, although it may designate the information as confidential. The order also allows production in response to a lawful subpoena or other compulsory process, subject to advance notice to the producing person when permitted.

Privilege, end of case, and enforcement

If privileged or attorney-work-product material is accidentally disclosed, the disclosure does not waive the protection. The receiving party must return or destroy the material within five business days after a claim of inadvertent disclosure and provide counsel’s certification. The producing party must then provide a privilege log, and the receiving party may ask the court to order production. The producing party retains the burden of proving that the material is privileged or otherwise protected.

The order continues after the litigation ends. Within 30 days after final disposition, recipients generally must return or destroy confidential discovery material and certify that they kept no copies or other reproductions, although attorneys specifically retained for the case may keep archival copies of specified case-related materials subject to the order. The court retains jurisdiction to enforce the order, and willful violations may result in contempt of court. Judge Jennifer H. Rearden entered the order as stipulated and agreed by the parties.

The authoritative version

Read the full 8-page opinion on CourtListener, the free public archive maintained by the Free Law Project.

Open opinion PDF →
Summary written with AI assistance. See how summaries are made. Spot something wrong? Tell us.